|
The Maine Immunization Program will be hosting a lunch and learn webinar on June 13 @ 12:00 PM and will focus on the PreHevbrio Hepatitis B vaccine for adults 19-59 years.
We are pleased to be joined by experts from the manufacturer, VBI Vaccines, to discuss the 3-antigen vaccine that is now available through MIP's adult 317 program for adults who are under or uninsured.
We invite providers to join us for this exciting opportunity to learn more about the vaccine.
Topic: The Maine Immunization Program Educational Webinar
Time: Jun 13, 2024 12:00 PM
Join Zoom Meeting
Meeting ID: 842 4800 6212
Passcode: 65057837
The Maine Immunization Program has a limited supply of adult vaccine posters available to order to help facilities promote adult vaccinations.
If you are interested in ordering, please send your requests to: MEAdultVaccine@maine.gov.
Due to the the limited supply available, we ask that providers only request one copy of each poster.
People of all ages need Tetanus Vaccines
Shingles - Did You Know?
New Immunizations to Protect Against RSV
Pneumococcal Conjugate Vaccine - Not Just for Children
Flu - Wild to Mild
Grown Ups Need Shots Too! |
Pfizer has begun to use a new Packing List with the 12+ COVID-19 "Never Frozen" shipments. As seen in the screenshot below, this packing list contains information listed on it showing the date and time by which the product should be received. If the shipment is not received within the stated time on packing list, there are instructions for the recipient to contact Pfizer Customer Service to determine product viability.
Pfizer Customer Service: 800-666-7248
On May 9, 2024, the U.S. CDC announced an earlier than anticipated end date for the Bridge
Access Program (BAP). The BAP currently provides free COVID-19 vaccines to adults without health insurance and adults whose insurance does not cover all COVID-19 vaccine costs. The program, originally scheduled to end in December 2024, will now end in August 2024.
The Maine CDC urges adults who may be under or uninsured to get vaccinated now
while this vaccine is available to them at no cost.
Older adults are the most vulnerable to severe illness from COVID-19 infection. A large
proportion of hospitalizations and deaths that occurred last year were among those aged 65 and older. With COVID-19 continuing to circulate and protection waning among this age group, we
encourage those 65 years and older to follow U.S. CDC recommendations to
receive a dose of the updated 2023-2024 COVID-19 vaccine and get an additional dose
administered ≥4 months after the initial dose from this 2023 - 2024 season.
Although a new COVID-19 vaccine will be available for the upcoming 2024 - 2025 season, we encourage those who are not currently up to date to get vaccinated now, rather than waiting for the fall. |
